neoplasm malignant
Showing 1 - 25 of 38
5-Aminolevulinic Acid Gliolan®: Usage Increase Proposal for
Not yet recruiting
- High Grade Glioma
- +10 more
- 5-Aminolevulinic Acid (5-ALA) Gliolan®
- Fluorescence-Guided Surgery using 5-aminolevulinic acid (5-ALA)
-
Guayaquil, Guayas, EcuadorSociedad de Lucha Contra el Cáncer
Apr 28, 2023
Tumor Malignant Trial in Napoli (CLG)
Active, not recruiting
- Neoplasm Malignant
- CLG
-
Napoli, Italy
- +1 more
Apr 18, 2023
Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,
Not yet recruiting
- Advanced Cancer
- +16 more
- Fosifloxuridine Nafalbenamide
- +3 more
-
Birmingham, United Kingdom
- +3 more
Feb 1, 2023
Mental Disorders, Psychosocial Distress and Care Needs of
Recruiting
- Neoplasm Malignant
-
Leipzig, Saxony, GermanyDepartment of Medical Psychology and Medical Sociology, Universi
May 17, 2022
Cancer, Tumor Malignant Trial in New Orleans (Multimedia Psychoeducational Intervention, Enhanced Usual Care)
Recruiting
- Cancer
- Neoplasm Malignant
- Multimedia Psychoeducational Intervention
- Enhanced Usual Care
-
New Orleans, Louisiana
- +1 more
Apr 25, 2022
Tumor Malignant Trial in Worldwide (SAR245408, SAR245409)
Completed
- Neoplasm Malignant
-
Birmingham, Alabama
- +20 more
Mar 30, 2022
Tumor Malignant, Tumor, Experimental, Solid Tumor, Adult Trial in Taipei (JS014, Interleukin 21 and humanized anti-human serum
Active, not recruiting
- Neoplasm Malignant
- +3 more
- JS014, Interleukin 21 and humanized anti-human serum albumin VHH antibody
- Pembrolizumab - anti-PD-1 antibody
-
Taipei, TaiwanWanfang Hospital -Taipei Medical University
Mar 16, 2022
Tumor Malignant Trial in Baton Rouge (Multimodal Lifestyle Program)
Recruiting
- Neoplasm Malignant
- Multimodal Lifestyle Program
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Feb 7, 2022
Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)
Recruiting
- Urothelial Carcinoma
- +20 more
- IK-175
- IK-175 and nivolumab
-
Gilbert, Arizona
- +9 more
Feb 3, 2022
Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)
Recruiting
- Advanced Cancer
- +9 more
- COM701
- COM701 with Opdivo (Nivolumab).
-
Los Angeles, California
- +10 more
Jan 25, 2022
iKnife REIMS Project
Recruiting
- Neoplasms
- Neoplasm Malignant
- Rapid Evaporative Ionisation Mass Spectrometry (REIMS)
-
London, United Kingdom
- +1 more
Sep 1, 2021
Tumor Malignant, Breast Cancer, Ovarian Cancer Trial in Leiden (Shorter PICT)
Completed
- Neoplasm Malignant
- +2 more
- Shorter PICT
-
Leiden, NetherlandsLUMC
Mar 30, 2021
Tumor Malignant Trial in San Antonio (PSB205)
Recruiting
- Neoplasm Malignant
- PSB205
-
San Antonio, TexasNext Oncology
Nov 23, 2020
Breast, Tumor Malignant, Female Trial in Pavia (Palbociclib, Letrozole 2.5mg, Fulvestrant)
Completed
- Breast
- +2 more
- Palbociclib
- +2 more
-
Pavia, ItalyIstituti Clinici Scientifici Maugeri IRCCS
Aug 20, 2020
Tumors, Tumor Malignant, Advanced Cancer Trial in Seattle
Recruiting
- Neoplasms
- +4 more
-
Seattle, WashingtonAIMS Institute
Aug 1, 2020
Body Mass Index and Quality of Life in Cancer Patients
Unknown status
- Neoplasm Malignant
- +2 more
-
Rome, ItalyTor Vergata University Hospital
Mar 12, 2019
Evaluation of End of Life Quality of Care
Completed
- Neoplasm Malignant
- +2 more
-
Paris, Ile De France, France
- +4 more
Dec 12, 2018
Tumor, Solid, Cancer, Metastatic, Tumor Malignant Trial (SHR9146+SHR-1210, SHR9146+SHR-1210+Apatinib)
Unknown status
- Tumor, Solid
- +2 more
- (no location specified)
Jun 2, 2018